Where does DR. Reddy's Laboratories Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), DR. Reddy's Laboratories Limited ranks #3,678 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does DR. Reddy's Laboratories Limited hold?

DR. Reddy's Laboratories Limited holds 99 US utility patents granted between 2015 and 2025, spanning 20 technology areas.

What is DR. Reddy's Laboratories Limited's Innovation Score?

DR. Reddy's Laboratories Limited has an Innovation Score of 43.7 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is DR. Reddy's Laboratories Limited's patent grant rate increasing or decreasing?

DR. Reddy's Laboratories Limited's recent grant velocity is -64% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for DR. Reddy's Laboratories Limited's patents?

DR. Reddy's Laboratories Limited's patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the DR. Reddy's Laboratories Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

DR. Reddy's Laboratories Limited

Q: What technology areas does DR. Reddy's Laboratories Limited focus on?

DR. Reddy's Laboratories Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 70 patents. Grants appear in 20 CPC subclasses total.

USPTO PatentsView assignee record - 99 granted patents across 20 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dr. ranks #3,678 of 49,997 tracked US assignees by granted-patent volume, with 99 patents across 20 technology areas.

#3,678
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.7/100): 17.0
avg claims per patent: -64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3678 · Foreign Corporation #3,678 · 99 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 99 grants
TOP-DECILE #3,678/49,997
PHOTO-FINISH BorgWarner Ludwigsburg
CPC-FOCUS A61P · 20 areas
INNOV-PAR 43.7/100
CLAIMS-RICH 17.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: BorgWarner Ludwigsburg GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
BOS & KG · near

44
ConsumerInfo com · near

44
DR Reddy's Laborator… · this assignee

44
NCS Multistage · near

44
Technoprobe S P A · near

44
3D Lighting… · lowest

7

What this shows Dr.'s Innovation Score is 43.7/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Dr.'s grants concentrate

DR. Reddy's Laboratories Limited is a focused PatentsView assignee: 20 CPC subclasses with 70.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (18 grants) versus a trough of 1 in 2023. By volume, Dr. sits between BorgWarner Ludwigsburg GmbH and Fidelity Information Services, LLC.

Dr.'s three-year grant acceleration

From 2019–2021 to 2022–2024, DR. Reddy's Laboratories Limited moved from 26 to 7 grants (0.27x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Borgwarner Ludwig…

99
Christie Digital…

99
Cooledge Lighting

99
Corteva Agriscien…

99
Dura Operating

99
ESS Tech

99
Exel Industries

99
Fidelity Informat…

99
DR Reddy's Labora… ◀

99

What this shows DR. holds 99 patents at rank #3,678, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near DR

By rank, the assignees closest to #3,678 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in DR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for DR, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

ConsumerInfo.com, Inc. 44 NCS Multistage Inc. 44 BOS GMBH & Co. KG 44 Technoprobe S.P.A. 44

Similar claim depth

Nearest assignees by average claims per patent (17.0 here).

Wangs Alliance Corporation 17.0 avg LDR Medical 17.0 avg EGALAX_EMPIA Technology Inc. 17.0 avg Cedars Sinai Medical Center 17.0 avg

Dr.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

DR. Reddy's Laboratories Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	14	14.1%
2016	18	18.2%
2017	16	16.2%
2018	17	17.2%
2019	7	7.1%
2020	10	10.1%
2021	9	9.1%
2022	4	4.0%
2023	1	1.0%
2024	2	2.0%
2025partial year	1	1.0%

Which technologies does DR. Reddy's Laboratories Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 70

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 63

C07D - Heterocyclic Compounds 54

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 15

Y02A - Technologies FOR Adaptation TO Climate Change 12

C07K - Peptides 10

C07C - Acyclic OR Carbocyclic Compounds 8

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 7

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 4

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 4

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C07J - Steroids 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

B01D - Separation 2

Top 15 of 20 technology areas

Where it ranks

Overall rank by patents

#3,678

of 49,997 tracked assignees

Innovation Score

43.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

DR. Reddy's Laboratories Limited's patent record in context - here's where to go next.

DR. Reddy's Laboratories Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 70.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,678 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare DR. Reddy's Laboratories Limited against BorgWarner Ludwigsburg GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.